Global Blood Therapeutics, Inc. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6a840c5d-f260-4a87-b1ab-3d0ac28584ff/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $194.7M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001781 |
| FY 2020 | $123.8M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-054629 |
| FY 2019 | $2.1M | 2019-01-01 – 2019-12-31 | evidence 0001193125-20-050084 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Global Blood Therapeutics, Inc. — all facts · Net Income · Operating Income